课题基金 / 基金详情

Optimization and Validation of High-throughput Anti-influenza Peptide Immunoassays

Optimization and Validation of High-throughput Anti-influenza Peptide Immunoassays
高通量抗流感肽免疫分析的优化和验证
批准号:
183300
负责人:
Kollmann Tobias R
金额:
$7.29万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2009
资助国家:
加拿大
项目状态:
已结题
起止时间:
2009-04-01 至 2010-04-01

项目摘要

项目成果

Kollmann Tobias R的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A flu outbreak can get out of hand and become a pandemic when the influenza virus responsible for the disease is an entirely new flavor that had not been seen by the human population, and a vaccine against it is yet to be developed. Vaccine candidates wil
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lower GBP1 expression reduces human host defense against Listeria monocytogenes
  • 批准号:
    280692
  • 项目类别:
    Operating Grants
  • 资助金额:
    $30.6万
  • 财政年份:
    2013
  • 负责人:
    Kollmann Tobias R
  • 依托单位:
Maternal-Infant Microbiome and Immunity (MIMI) Network
  • 批准号:
    259841
  • 项目类别:
    Operating Grants
  • 资助金额:
    $43.71万
  • 财政年份:
    2011
  • 负责人:
    Kollmann Tobias R
  • 依托单位:
Vaccines for Asthma and Allergies - an Immune-Prophylactic and -Therapeutic Approach
  • 批准号:
    183523
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2009
  • 负责人:
    Kollmann Tobias R
  • 依托单位:
海外基金